Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Remedy Q4’25: The stakes are high

Remedy Entertainment

Remedy's investment story is entering a pivotal year, as the company is about to release what is arguably its most important game so far: Control Resonant. For the value creation of Remedy's share, it is essential to succeed with the release. Analyst Atte Riikola summarizes.

Stay up to date
Analyst Interviews

Recent videos

Intervju med Resitu Medicals VD under SCF:s 17:e Kapitalmarknadsdag Life Science
2026-03-19 08:10
Interview with Saniona's CEO during SCF's 17th Capital Markets Day Life Science
2026-03-19 08:09 Saniona
Intervju med Ortomas VD under SCF:s 17:e Kapitalmarknadsdag Life Science
2026-03-19 08:07 Ortoma
Intervju med Newbury Pharmaceuticals VD under SCF:s 17:e Kapitalmarknadsdag Life Science
2026-03-19 08:07 Newbury Pharmaceuticals
Intervju med Devysers CFO under SCF:s 17:e Kapitalmarknadsdag Life Science
2026-03-19 08:06 Devyser Diagnostics
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.